TCam-2 seminoma cell line exhibits characteristic foetal germ cell responses to TGF-beta ligands and retinoic acid

International Journal of Andrology

Volumn 34, Issue 4 PART 2, 2011, Pages

  Young, J C ^a,b   Jaiprakash, A ^b   Mithraprabhu, S ^b   Itman, C ^a,b   Kitazawa, R ^c   Looijenga, L H J ^d   Loveland, K L ^a,b  

^a Australian Government Australian Research Council   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Activin; Activin receptors; BMP; Testis cancer

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 2A; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BONE MORPHOGENETIC PROTEIN 4; CELL MARKER; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; STEM CELL FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; GERM CELL; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA; TCAM 2 CELL;

ACTIVIN RECEPTORS, TYPE II; ACTIVINS; ADAPTOR PROTEIN COMPLEX 2; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 4; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GERM CELLS; HOMEODOMAIN PROTEINS; HUMANS; LIGANDS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-KIT; REPRESSOR PROTEINS; SEMINOMA; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 79960854756     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01170.x     Document Type: Article

References (52)

1. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E & Leffers H. (2004) Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64, 4736-4743.
2. Anderson RA, Cambray N, Hartley PS & McNeilly AS. (2002) Expression and localization of inhibin alpha, inhibin/activin betaA and betaB and the activin type II and inhibin beta-glycan receptors in the developing human testis. Reproduction 123, 779-788.
3. Atkin NB & Baker MC. (1982) Specific chromosome change, i(12p), in testicular tumours? Lancet 2, 1349.
4. Biermann K, Goke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H & Büttner R. (2007a) c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213, 311-318.
5. Biermann K, Heukamp LC, Steger K, Zhou H, Franke FE, Sonnack V et al. (2007b) Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumours. Cancer Genomics Proteomics 4, 359-367.
6. Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S et al. (2006) Retinoid signalling determines germ cell fate in mice. Science 312, 596-600.
7. Caricasole AA, van Schaik RH, Zeinstra LM, Wierikx CD, van Gurp RJ, van den Pol M et al. (1998) Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene 16, 95-103.
8. Chuva de Sousa Lopes SM, Hayashi K & Surani MA. (2007) Proximal visceral endoderm and extraembryonic ectoderm regulate the formation of primordial germ cell precursors. BMC Dev Biol 7, 140.
9. Clark AT, Rodriguez RT, Bodnar MS, Abeyta MJ, Cedars MI, Turek PJ, Firpo MT & Reijo Pera RA. (2004) Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome GBI 12p13, a hotspot for teratocarcinoma. Stem Cells 22, 169-179.
10. Cobellis L, Cataldi P, Reis FM, De Palo G, Raspagliesi F, Pilotti S, Arcuri F & Petraglia F. (2001) Gonadal malignant germ cell tumours express immunoreactive inhibin/activin subunits. Eur J Endocrinol 145, 779-784.
11. Di Simone N, Hall HA, Welt C & Schneyer AL. (1998) Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumour cells. Endocrinology 139, 1147-1155.
12. Dias V, Meachem S, Rajpert-De Meyts E, McLachlan R, Manuelpillai U & Loveland KL. (2008) Activin receptor subunits in normal and dysfunctional adult human testis. Hum Reprod 23, 412-420.
13. Dudley BM, Runyan C, Takeuchi Y, Schaible K & Molyneaux K. (2007) BMP signalling regulates PGC numbers and motility in organ culture. Mech Dev 124, 68-77.
14. Eckert D, Biermann K, Nettersheim D, Gillis AJ, Steger K, Jäck HM, Müller AM, Looijenga LH & Schorle H. (2008a) Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in foetal germ cells, CIS/IGCNU and germ cell tumours. BMC Dev Biol 8, 106.
15. Eckert D, Nettersheim D, Heukamp LC, Kitazawa S, Biermann K & Schorle H.. (2008b) TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell Tissue Res 331, 529-538.
16. Ezeh UI, Turek PJ, Reijo RA & Clark AT. (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104, 2255-2265.
17. Goddard NC, McIntyre A, Summersgill B, Gilbert D, Kitazawa S & Shipley J. (2007) KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. Int J Androl 30: 337-348; discussion 349.
18. Goddard NC, McIntyre A, Gilbert D, Kitazawa S & Shipley J. (2010) No evidence for V600E BRAF mutation in the seminoma cell line TCam-2. Genes Chromosom Cancer 49, 963-966.
19. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW & Robb L. (2005) The pluripotency homeobox gene NANOG is expressed in human germ cell tumours. Cancer 104, 2092-2098.
20. Haston KM, Tung JY & Reijo Pera RA. (2009) DAZL functions in maintenance of pluripotency and genetic and epigenetic programs of differentiation in mouse primordial germ cells in vivo and in vitro. PLoS ONE 4, e5654.
21. Hoei-Hansen CE, Nielsen JE, Almstrup K, Hansen MA, Skakkebaek NE, Rajpert-DeMeyts E & Leffers H. (2004a) Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod 10, 423-431.
22. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H & Rajpert-De Meyts E. (2004b) Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumours. Clin Cancer Res 10, 8521-8530.
23. Hoei-Hansen CE, Almstrup K, Nielsen JE, Brask Sonne S, Graem N, Skakkebaek NE, Leffers H & Rajpert-De Meyts E. (2005) Stem cell pluripotency factor NANOG is expressed in human foetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 47, 48-56.
24. Itman C, Mendis S, Barakat B & Loveland KL. (2006) All in the family: TGF-beta family action in testis development. Reproduction 132, 233-246.
25. Itman C, Whiley PA, Zhou W, Meistrich M, Sahin Z & Loveland KL. (2009) Regulated production of SnoN2 is a feature of testicular differentiation. Microsc Res Tech 72, 833-844.
26. de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ et al. (2008) Further characterization of the first seminoma cell line TCam-2. Genes Chromosom Cancer 47, 185-196.
27. Kee K, Angeles VT, Flores M, Nguyen HN & Reijo Pera RA. (2009) Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature 462, 222-225.
28. Kerr CL, Hill CM, Blumenthal PD & Gearhart JD. (2008) Expression of pluripotent stem cell markers in the human foetal testis. Stem Cells 26, 412-421.
29. Kim J, Chu J, Shen X, Wang J & Orkin SH. (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061.
30. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ & Chaganti RS. (2006) Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumours. Cancer Res 66, 820-827.
31. Koshimizu U, Watanabe M & Nakatsuji N. (1995) Retinoic acid is a potent growth activator of mouse primordial germ cells in vitro. Dev Biol 168, 683-685.
32. Lifschitz-Mercer B, Elliott DJ, Issakov J, Leider-Trejo L, Schreiber L, Misonzhnik F, Eisenthal A & Maymon BB. (2002) Localization of a specific germ cell marker, DAZL1, in testicular germ cell neoplasias. Virchows Arch 440, 387-391.
33. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE et al. (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumours. Cancer Res 63, 2244-2250.
34. Mendis SH, Meachem SJ, Sarraj MA & Loveland KL. (2011) Activin A balances sertoli and germ cell proliferation in the foetal mouse testis. Biol Reprod 84, 379-91.
35. Mithraprabhu S, Mendis S, Meachem SJ, Tubino L, Matzuk MM, Brown CW & Loveland KL. (2010) Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo. Biol Reprod 82, 980-90.
36. National Cancer Institute, U. N. I. o. H.. (2009) Surveillance Epidemiology and End Results. Available at.
37. Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, Sano M et al. (2005) Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436, 207-213.
38. Olesen IA, Sonne SB, Hoei-Hansen CE, Rajpert-De Meyts E & Skakkebaek NE. (2007) Environment, testicular dysgenesis and carcinoma in situ testis. Best Pract Res Clin Endocrinol Metab 21, 462-478.
39. Oosterhuis JW & Looijenga LH. (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5, 210-222.
40. Pauls K, Schorle H, Jeske W, Brehm R, Steger K, Wernert N, Büttner R & Zhou H. (2006) Spatial expression of germ cell markers during maturation of human foetal male gonads: an immunohistochemical study. Hum Reprod 21, 397-404.
41. Richards AJ, Enders GC & Resnick JL. (1999) Activin and TGFbeta limit murine primordial germ cell proliferation. Dev Biol 207, 470-475.
42. Roy A & Matzuk MM. (2006) Deconstructing mammalian reproduction: using knockouts to define fertility pathways. Reproduction 131, 207-219.
43. van Schaik RH, Wierikx CD, Looijenga LH, Oosterhuis JW & de Jong FH. (1997) Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs. Br J Cancer 76, 1191-1198.
44. Scott HM, Mason JI & Sharpe RM. (2009) Steroidogenesis in the foetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev 30, 883-925.
45. Skakkebaek NE, Berthelsen JG, Giwercman A & Müller J. (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10, 19-28.
46. Skakkebaek NE, Rajpert-De Meyts E & Main KM. (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16, 972-978.
47. Sonne SB, Kristensen DM, Novotny GW, Olesen IA, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E & Leffers H. (2008) Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int J Androl 31, 275-287.
48. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO & Thomson JA. (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumours. Proc Natl Acad Sci USA 100, 13350-13355.
49. Stoop H, Honecker F, van de Geijn GJ, Gillis AJ, Cools MC & de Boer M. (2008) Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 216, 43-54.
50. Summersgill B, Osin P, Lu YJ, Huddart R & Shipley J. (2001) Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 85, 213-220.
51. Ulbright TM, Amin MB & Young RH. (1999) Atlas of tumour pathology. Tumours of the testis, adnexa, spermatic cord, and scrotum. 1-385.
52. Zeeman AM, Stoop H, Boter M, Gillis AJ, Castrillon DH, Oosterhuis JW & Looijenga LH. (2002) VASA is a specific marker for both normal and malignant human germ cells. Lab Invest 82, 159-166.